Core Laboratories (NYSE:CLB) Shares Gap Down – Here’s What Happened

Shares of Core Laboratories Inc. (NYSE:CLB) gapped down before the market opened on Tuesday . The stock had previously closed at $16.87, but opened at $16.05. Core Laboratories shares last traded at $16.4070, with a volume of 116,519 shares trading hands.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a research note on Monday, December 29th. Four analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $12.50.

Core Laboratories Trading Down 4.3%

The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.57 and a current ratio of 2.07. The firm has a market cap of $752.04 million, a P/E ratio of 24.13, a P/E/G ratio of 14.14 and a beta of 1.10. The firm has a 50 day simple moving average of $18.04 and a 200 day simple moving average of $15.88.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The firm had revenue of $138.26 million for the quarter, compared to the consensus estimate of $130.40 million. During the same period in the prior year, the firm posted $0.22 earnings per share. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. On average, equities research analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 9th. Shareholders of record on Monday, February 16th were issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, February 13th. Core Laboratories’s dividend payout ratio (DPR) is presently 5.97%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. CWA Asset Management Group LLC bought a new stake in shares of Core Laboratories during the 4th quarter valued at about $9,978,000. Ariel Investments LLC raised its stake in Core Laboratories by 25.5% in the second quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company’s stock valued at $149,489,000 after purchasing an additional 2,634,438 shares in the last quarter. Gendell Jeffrey L lifted its position in Core Laboratories by 24.6% during the second quarter. Gendell Jeffrey L now owns 569,471 shares of the oil and gas company’s stock valued at $6,560,000 after purchasing an additional 112,475 shares during the last quarter. Geode Capital Management LLC grew its stake in Core Laboratories by 3.0% in the 2nd quarter. Geode Capital Management LLC now owns 1,114,560 shares of the oil and gas company’s stock worth $12,842,000 after buying an additional 32,934 shares in the last quarter. Finally, Pacific Ridge Capital Partners LLC purchased a new position in Core Laboratories in the 3rd quarter worth approximately $525,000. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.